Why the study?
Astrocytes in the hypothalamic paraventricular nucleus promote ventricular arrhythmia after AMI, but the underlying mechanisms remain unclear.
Does GSK2606414 microinjection into the hypothalamus reduce ventricular electrical instability and central inflammation in rats after acute myocardial infarction?
Does GSK2606414 microinjection into the hypothalamus reduce ventricular electrical instability and central inflammation in rats after acute myocardial infarction?
Inhibition of ER stress in PVN astrocytes via GSK2606414 reduces central inflammation and ventricular electrical instability in rats 24 hours after acute myocardial infarction.
May implicate PVN astrocyte PERK signaling in post-AMI VA; hypothesis-generating with no clinical implications yet.
Introduction Astrocytes in paraventricular nucleus of hypothalamus (PVN) promote the occurrence of ventricular arrhythmia (VA) after acute myocardial infarction (AMI). However, the mechanism is unclear. The purpose of this study was to investigate the changes of astrocytes in the PVN after AMI, which is involved in ventricular electrical instability in rats. Methods The rats were randomly divided into 4 groups: sham operation (SH), AMI, AMI + Vehicle (4 μl for each), AMI + GSK2606414(PERK phosphorylation inhibitor, 90 μg/4 μl for each). PVN was administered by microinjection. Results After 24 h, the AMI and AMI + Vehicle groups had substantially greater levels of hypothalamic astrocyte activation, endoplasmic reticulum (ER) stress, and central inflammation (TNF-α and IL-6) compared to the SH group (P < 0.05). GSK2606414 microinjection in hypothalamus had no significant effect on glial fibrillary acidic protein (GFAP) positive cells and their pathologic morphology in PVN of AMI + Vehicle group, but significantly reduced ER stress (PERK/CHOP) in the group, alleviating central inflammation and activation of central neurons (P < 0.05). Cytological studies confirmed this. Conclusion As a result, 24 h after AMI, PVN astrocytes underwent ER stress via PERK/CHOP pathway, which caused central inflammation, sympathetic neuron activation, and increased ventricular electrical activity instability. GSK2606414 microinjection into hypothalamus decreased sympathetic nerve excitement and VA occurrence in AMI rats by inhibiting ER stress of PVN astrocytes.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: